CLINICAL_TRIALS
trial_result
· 2015-02-11
Clinical Trial Update: Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2]
Summary
Phase 2 trial update of pegylated asparaginase with combination chemotherapy in newly diagnosed acute lymphoblastic leukemia (ALL) has been terminated; results …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OHSU Knight Cancer Institute | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2015-02-11